Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
123.64
+2.14 (1.76%)
Aug 21, 2026, 11:30 AM EDT - Market open
Kymera Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -299.6 | -311.35 | -223.86 | -146.96 | -154.81 | -100.22 |
Depreciation & Amortization | 8.23 | 8.31 | 7.37 | 3.57 | 2.98 | 2.4 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.02 |
Asset Writedown & Restructuring Costs | 3.86 | 3.86 | 4.93 | - | - | - |
Loss (Gain) From Sale of Investments | -9.29 | -8.88 | -13.98 | -5.23 | 0.89 | 5.81 |
Stock-Based Compensation | 65.2 | 59.9 | 55.01 | 43.12 | 35.48 | 24.97 |
Change in Accounts Receivable | 20 | 0.95 | 17.82 | -16.23 | -2.4 | 1.3 |
Change in Accounts Payable | 3.13 | -1.97 | -0.31 | 2.04 | 0.25 | 0.05 |
Change in Unearned Revenue | -40 | 20.79 | -41.08 | -8.61 | -37.77 | -69.36 |
Change in Other Net Operating Assets | 11.72 | -4.5 | -0.4 | 25.48 | 2.3 | 6.08 |
Operating Cash Flow | -236.76 | -232.89 | -194.5 | -102.83 | -153.09 | -128.95 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.19 | -1.45 | -12.84 | -34.48 | -2.84 | -1.6 |
Investment in Securities | -751.3 | -519.61 | -391.24 | 174.37 | 23.36 | -98.24 |
Investing Cash Flow | -752.49 | -521.06 | -404.08 | 139.89 | 20.52 | -99.84 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -1.49 | -1.58 | -0.08 | -1.13 | -0.85 |
Net Debt Issued (Repaid) | -1.7 | -1.49 | -1.58 | -0.08 | -1.13 | -0.85 |
Issuance of Common Stock | 831.51 | 1,044 | 638.79 | 4.27 | 154.3 | 251.53 |
Other Financing Activities | -51.9 | -51.9 | -28.36 | - | -0.17 | -0.4 |
Financing Cash Flow | 777.92 | 990.71 | 608.85 | 4.19 | 153 | 250.28 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -211.34 | 236.76 | 10.27 | 41.25 | 20.43 | 21.5 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -237.96 | -234.34 | -207.34 | -137.31 | -155.92 | -130.54 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -226.63% | -597.64% | -440.47% | -174.71% | -332.98% | -179.24% |
Free Cash Flow Per Share | -2.55 | -2.77 | -2.76 | -2.35 | -2.89 | -2.72 |
Levered Free Cash Flow | -144.07 | -136.04 | -126.83 | -97.62 | -90.21 | -58.3 |
Unlevered Free Cash Flow | -143.86 | -135.81 | -126.68 | -97.49 | -90.1 | -58.19 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.28 | 0.31 | 0.21 | 0.16 | 0.18 | 0.16 |
Change in Working Capital | -5.16 | 15.27 | -23.97 | 2.68 | -37.62 | -61.92 |